Beneficial and Adverse Effects of Correction of Anaemia by Recombinant Human Erythropoietin in Patients on Maintenance Haemodialysis

Autor:	P. Grützmacher, U. Nattermann, M. Pollok, M. Bergmann, E. Reimers, T. Weinreich
Rok vydání:	2015
Předmět:	law Erythropoietin business.industry Maintenance haemodialysis Recombinant DNA medicine In patient Bioinformatics Adverse effect business law.invention medicine.drug
DOI:	10.1159/000416008
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::aa2c3cb6064f61de8ba60cb51dff480c https://doi.org/10.1159/000416008 Zobrazit plný text záznamu